Marino Stram & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-5,304
| Closed | -$308K | – | 169 |
|
2023
Q3 | $308K | Sell |
5,304
-144
| -3% | -$8.36K | 0.09% | 123 |
|
2023
Q2 | $348K | Buy |
5,448
+4
| +0.1% | +$256 | 0.1% | 119 |
|
2023
Q1 | $377K | Buy |
5,444
+27
| +0.5% | +$1.87K | 0.11% | 110 |
|
2022
Q4 | $390K | Sell |
5,417
-1,463
| -21% | -$105K | 0.12% | 106 |
|
2022
Q3 | $489K | Buy |
6,880
+71
| +1% | +$5.05K | 0.18% | 88 |
|
2022
Q2 | $524K | Sell |
6,809
-14
| -0.2% | -$1.08K | 0.18% | 89 |
|
2022
Q1 | $498K | Sell |
6,823
-194
| -3% | -$14.2K | 0.16% | 102 |
|
2021
Q4 | $437K | Sell |
7,017
-444
| -6% | -$27.7K | 0.13% | 109 |
|
2021
Q3 | $441K | Sell |
7,461
-13,173
| -64% | -$779K | 0.15% | 101 |
|
2021
Q2 | $1.38M | Buy |
20,634
+13,791
| +202% | +$922K | 0.36% | 65 |
|
2021
Q1 | $432K | Sell |
6,843
-292
| -4% | -$18.4K | 0.17% | 89 |
|
2020
Q4 | $443K | Buy |
7,135
+1,325
| +23% | +$82.3K | 0.2% | 76 |
|
2020
Q3 | $350K | Buy |
5,810
+184
| +3% | +$11.1K | 0.19% | 78 |
|
2020
Q2 | $331K | Buy |
5,626
+890
| +19% | +$52.4K | 0.2% | 77 |
|
2020
Q1 | $264K | Sell |
4,736
-1,889
| -29% | -$105K | 0.2% | 73 |
|
2019
Q4 | $425K | Buy |
6,625
+873
| +15% | +$56K | 0.28% | 57 |
|
2019
Q3 | $292K | Sell |
5,752
-1,069
| -16% | -$54.3K | 0.21% | 66 |
|
2019
Q2 | $309K | Sell |
6,821
-583
| -8% | -$26.4K | 0.23% | 64 |
|
2019
Q1 | $353K | Buy |
7,404
+213
| +3% | +$10.2K | 0.25% | 55 |
|
2018
Q4 | $374K | Sell |
7,191
-60
| -0.8% | -$3.12K | 0.33% | 51 |
|
2018
Q3 | $450K | Sell |
7,251
-43
| -0.6% | -$2.67K | 0.36% | 48 |
|
2018
Q2 | $404K | Sell |
7,294
-165
| -2% | -$9.14K | 0.36% | 50 |
|
2018
Q1 | $472K | Buy |
7,459
+135
| +2% | +$8.54K | 0.44% | 49 |
|
2017
Q4 | $449K | Buy |
+7,324
| New | +$449K | 0.41% | 48 |
|